Skip to main content

Table 1 Demographic and clinical characteristics of participants (N = 300)

From: Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study

  Total respondents Willing to participate P-value
  N %  
Total 297 49.8  
Age    
  ≤55 71 60.6 0.037
  56-65 130 50.8  
  >65 96 40.6  
Race/Ethnicity    
  White 250 51.2 0.28
  Non-White 47 42.6  
Educational level    
  High school or less 121 35.5 <0.001
  College 76 69.7  
  Graduate/professional school 99 51.5  
Employment    
  Full-time 112 50.9 0.54
  Part-time 40 42.5  
  Not currently 141 52.5  
Stage    0.70
  I 99 45.4  
  II 141 49.6  
  III 32 53.1  
Chemotherapy    0.17
  No 118 44.9  
  Yes 179 53.1  
Radiation therapy    0.017
  No 106 40.6  
  Yes 191 55.0  
Type of AI    0.056
  Exemestane 57 43.9  
  Anastrazole 171 46.8  
  Letrozole 69 62.3  
Months on AI 23.5 21.7 0.11
Prior acupuncture use    0.004
  No 271 47.2  
  Yes 26 76.9  
CAM user    <0.001
  No 114 36.8  
  Yes 183 57.9  
Co-morbidity    0.037
  None 86 59.3  
  Yes 211 46.0  
Joint pain during past 7 days    0.038
  None 54 35.2  
  Mild/moderate 189 51.8  
  Severe or more 53 58.5  
  Mean for WTP Std Dev.  
Acupuncture expectancy scale 11.5 4.07 <0.001
  1. Abbreviations: AI, Aromatase Inhibitor; CAM, complementary and alternative medicine.
  2. *P-value obtained by Chi-2 for categorical and T-test for continuous outcomes.
  3. Not all cells add up to 300 due to missing data.